Becotatug (JMT-101) is an IgG1 monoclonal antibody specifically designed to target the Epidermal Growth Factor Receptor (EGFR). This antibody can be conjugated with Afatinib and Osimertinib, enabling its use as a synthetic antibody-drug conjugate (ADC) for targeted cancer therapy. This feature allows for the precise delivery of therapeutic agents to EGFR-expressing cells, potentially enhancing treatment efficacy and reducing off-target effects.
Becotatug (JMT-101) is an IgG1 monoclonal antibody specifically designed to target the Epidermal Growth Factor Receptor (EGFR). This antibody can be conjugated with Afatinib and Osimertinib, enabling its use as a synthetic antibody-drug conjugate (ADC) for targeted cancer therapy. This feature allows for the precise delivery of therapeutic agents to EGFR-expressing cells, potentially enhancing treatment efficacy and reducing off-target effects.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
